These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling. Malde AK; Srivastava SS; Coutinho EC J Pept Sci; 2007 May; 13(5):287-300. PubMed ID: 17437246 [TBL] [Abstract][Full Text] [Related]
6. Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid. Green BD; Gault VA; Flatt PR; Harriott P; Greer B; O'Harte FP Arch Biochem Biophys; 2004 Aug; 428(2):136-43. PubMed ID: 15246869 [TBL] [Abstract][Full Text] [Related]
7. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations. Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844 [TBL] [Abstract][Full Text] [Related]
8. In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide. Hinke SA; Manhart S; Speck M; Pederson RA; Demuth HU; McIntosh CH Life Sci; 2004 Aug; 75(15):1857-70. PubMed ID: 15302229 [TBL] [Abstract][Full Text] [Related]
9. Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide. Kerr BD; Flatt AJ; Flatt PR; Gault VA Biochem Biophys Res Commun; 2011 Jan; 404(3):870-6. PubMed ID: 21184739 [TBL] [Abstract][Full Text] [Related]
10. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041 [TBL] [Abstract][Full Text] [Related]
11. A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis. Kim SJ; Choi WS; Han JS; Warnock G; Fedida D; McIntosh CH J Biol Chem; 2005 Aug; 280(31):28692-700. PubMed ID: 15955806 [TBL] [Abstract][Full Text] [Related]
12. Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo. Gault VA; O'Harte FP; Harriott P; Flatt PR Metabolism; 2003 Jun; 52(6):679-87. PubMed ID: 12800091 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide. Gault VA; O'Harte FP; Harriott P; Flatt PR Biochem Biophys Res Commun; 2002 Feb; 290(5):1420-6. PubMed ID: 11820780 [TBL] [Abstract][Full Text] [Related]
15. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion. Ehses JA; Lee SS; Pederson RA; McIntosh CH J Biol Chem; 2001 Jun; 276(26):23667-73. PubMed ID: 11323439 [TBL] [Abstract][Full Text] [Related]
16. Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand. Yaqub T; Tikhonova IG; Lättig J; Magnan R; Laval M; Escrieut C; Boulègue C; Hewage C; Fourmy D Mol Pharmacol; 2010 Apr; 77(4):547-58. PubMed ID: 20061446 [TBL] [Abstract][Full Text] [Related]
17. Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16). Irwin N; Green BD; Parker JC; Gault VA; O'Harte FP; Flatt PR Regul Pept; 2006 Jul; 135(1-2):45-53. PubMed ID: 16675042 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1. Pathak V; Vasu S; Flatt PR; Irwin N Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718 [TBL] [Abstract][Full Text] [Related]
19. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors. Moon MJ; Kim HY; Kim SG; Park J; Choi DS; Hwang JI; Seong JY Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Green BD; Gault VA; O'Harte FP; Flatt PR Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]